Quantitative Evaluation of Substantia Nigra Degeneration in Parkinson’s Disease using T1 mapping
Ayaka Yokota, Yasuhiro Fujiwara, Tetsuyoshi Hirai, Nobutaka Sakae, Naokazu Sasagasako, Takahisa Izumi, Kuniharu Ohi, Hiroyuki Kumazoe
Abstract
Ayaka Yokota, Yasuhiro Fujiwara, Tetsuyoshi Hirai, Nobutaka Sakae, Naokazu Sasagasako, Takahisa Izumi, Kuniharu Ohi, Hiroyuki Kumazoe
Abstract
We evaluated the T1 values of the whole and subregions of the substantia nigra (SN) in patients with Parkinson's disease (PD) to identify an imaging biomarker for the early diagnosis of PD. T1 values of the SN of patients with PD were significantly shorter than those of healthy controls and tended to be longer in the lateral part for both groups. T1 values may reflect the pathology of the SN and help assess the degeneration of the SN caused by PD.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
We evaluated the T1 values of the whole and subregions of the substantia nigra (SN) in patients with Parkinson's disease (PD) to identify an imaging biomarker for the early diagnosis of PD. T1 values of the SN of patients with PD were significantly shorter than those of healthy controls and tended to be longer in the lateral part for both groups. T1 values may reflect the pathology of the SN and help assess the degeneration of the SN caused by PD.
Key concepts: Substantia nigra, Parkinson's disease, Degeneration (medical), Biomarker, Disease, Pathology, Medicine, Degenerative disease